Literature DB >> 12602491

HPFP, a model propellant for pMDIs.

Philippe G A Rogueda1.   

Abstract

A novel model propellant for the study of the properties of pMDIs (pressurized metered-dose inhalers) at atmospheric pressure is proposed and extensively characterized. The reasons for the choice of this liquid, with its advantages and drawbacks, are explained and justified. Comparison with existing fluorinated propellants is also documented.

Mesh：

Substances：

Year:  2003        PMID： 12602491     DOI： 10.1081/ddc-120016682

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN： 0363-9045            Impact factor:   3.225


  8 in total

1.  Surface energy and interparticle forces correlations in model pMDI formulations.

Authors:  Daniela Traini; Philippe Rogueda; Paul Young; Robert Price
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

2.  Comparison of surfactants used to prepare aqueous perfluoropentane emulsions for pharmaceutical applications.

Authors:  Madhuvanthi A Kandadai; Praveena Mohan; Genyao Lin; Anthony Butterfield; Mikhail Skliar; Jules J Magda
Journal:  Langmuir       Date:  2010-04-06       Impact factor: 3.882

3.  In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers.

Authors:  Daniela Traini; Paul M Young; Philippe Rogueda; Robert Price
Journal:  Pharm Res       Date:  2006-11-14       Impact factor: 4.200

4.  Determination of reference ultrasound parameters for model and hydrofluoroalkane propellants using high-resolution ultrasonic spectroscopy.

Authors:  Susan Hoe; Paul M Young; Philippe Rogueda; Daniela Traini
Journal:  AAPS PharmSciTech       Date:  2008-05-06       Impact factor: 3.246

5.  Core-shell particles for the dispersion of small polar drugs and biomolecules in hydrofluoroalkane propellants.

Authors:  Libo Wu; Balaji Bharatwaj; Jayanth Panyam; Sandro R P da Rocha
Journal:  Pharm Res       Date:  2007-10-17       Impact factor: 4.200

6.  Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers.

Authors:  Josh D Engstrom; Jasmine M Tam; Maria A Miller; Robert O Williams; Keith P Johnston
Journal:  Pharm Res       Date:  2008-08-29       Impact factor: 4.200

7.  Protective Abilities of an Inhaled DPI Formulation Based on Sodium Hyaluronate against Environmental Hazards Targeting the Upper Respiratory Tract.

Authors:  Juhura G Almazi; Dina M Silva; Valentina Trotta; Walter Fiore; Hui X Ong; Daniela Traini
Journal:  Pharmaceutics       Date:  2022-06-22       Impact factor: 6.525

8.  Poly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epithelium.

Authors:  Denise S Conti; Daniel Brewer; Jordan Grashik; Sumant Avasarala; Sandro R P da Rocha
Journal:  Mol Pharm       Date:  2014-05-08       Impact factor: 4.939
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.